Optimus submits interim result of phase III clinical trials for Molnupiravir capsules
Jul 21, 2021, at 10:54 pm
Hyderabad/UNI: Optimus Pharma on Wednesday said that it has submitted the interim result of phase III clinical trials for orally administered Molnupiravir capsules on patients with mild covid infection.